Navigation Links
Tengion to Present at 27th Annual JP Morgan Healthcare Conference
Date:1/6/2009

Completed Phase 2 Bladder Augment Trial and Plans for Registration Trial to be Discussed

Breakthrough in Kidney Regeneration Program: Preclinical Progress to be Highlighted

EAST NORRITON, Pa., Jan. 6 /PRNewswire/ -- Tengion Inc., a clinical-stage organ regeneration company with products in urologic, vascular, and renal regeneration, today announced that Steven Nichtberger, M.D., president and chief executive officer, is scheduled to present at the 27th Annual JP Morgan Healthcare Conference on Monday, January 12, 2009 at 2:30 p.m. PST. The conference will be held January 12 - 15 at The Westin St. Francis Hotel in San Francisco.

For the first time, Dr. Nichtberger will discuss Tengion's completion of its Phase 2 clinical trial in patients with neurogenic bladder due to spina bifida and the company's plans for a Phase 3 trial of its Tengion Neo-Bladder Augment(R) in patients with neurogenic bladder, planned for initiation in the first half of 2009. Dr. Nichtberger will also present breakthrough preclinical data from Tengion's renal program.

"Regenerative medicine is on the verge of unimagined breakthroughs. Similar to the emergence of novel chemical, protein, and antibody therapeutics in the past few decades, the impact of regenerative medicine on human health is emerging with great promise in the new millennium," said Dr. Nichtberger. "Tengion is at the forefront of this space with a practical and proven organ regeneration technology platform with nearly a decade of human clinical experience. Recent preclinical advances in our renal program, which is focused on eliminating the need for dialysis in patients with emerging kidney failure, reinforce the promise and value of our technology platform. The past year has been filled with important milestones that position us well for 2009."

"Kidney regeneration from patients' own cells would become the standard of care for chronic renal failure therapy. Tengion's work on the neo-kidney is an important early step towards this goal," said Brian Pereira, MD, former President of the National Kidney Foundation, editor of the leading textbook, "Chronic Kidney Disease, Dialysis, & Transplantation," and Board member of Tengion, Inc.

About Tengion

Tengion is a clinical-stage organ regeneration company with products in urologic, vascular and renal regeneration based on its proprietary Autologous Organ Regeneration Platform(TM). Tengion uses biocompatible materials and a patient's own (autologous) cells to create neo-organs or neo-tissues that are designed to catalyze the body's innate ability to regenerate. Tengion is a fully-integrated organization, with scalable U.S. and European manufacturing and distribution capabilities, experienced research, development, clinical and commercial teams, and significant intellectual property. Tengion's product candidates may ultimately address the most critical problems facing organ and tissue failure patients, enabling people to lead healthier lives without donor transplants or the side effects of related therapies. For more information, please visit www.tengion.com.


'/>"/>
SOURCE Tengion
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
2. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
3. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
4. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
5. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
6. AtriCure to Present at Roth Capital Partners 2007 New York Conference
7. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
8. MDS to Present at Thomas Weisel Partners Healthcare Conference
9. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
10. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
11. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... SC (PRWEB) , ... March 24, 2017 , ... Digital ... is excited to announce the opening of a Greenville, South Carolina location. ... for digital progress in Greenville. , “We’ve been working with South Carolina clients for ...
(Date:3/24/2017)... , ... March 24, 2017 , ... The iaedp Foundation, ... other medical professionals caring for those suffering from the full spectrum of disordered eating, ... as eating disorders professionals from nearly all 50 states and several countries converged on ...
(Date:3/24/2017)... PA (PRWEB) , ... March 24, 2017 , ... ... Oncology Nursing Society (ONS) wanted to create a communications platform that positions them ... this goal, Elliance and ONS reinvented their online publication as an always-on, always-fresh ...
(Date:3/24/2017)... , ... March 24, 2017 , ... Viewers who like ... of critical historical facts, cultural practices, goods, services, and societal issues tend to appreciate ... look into the popular practice of utilizing running events for causes around the world. ...
(Date:3/24/2017)... ... March 24, 2017 , ... “Finding ... God #TruthwithGrace”: a devotional journal chronicling the writer’s path toward true communion with ... Walk with God #TruthwithGrace” is the creation of published author Lea Michelle Johnson, ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... YORK , March 24, 2017 ... and Equipment stocks, which are: Neovasc Inc. (NASDAQ: NVCN), Hologic ... Heart Inc. (NASDAQ: SSH ). These companies are ... its prior gains on Thursday, March 23 rd , 2017, ... afternoon, while shares of health care companies in the S&P ...
(Date:3/24/2017)... BOTHELL, Wash. , March 23, 2017 /PRNewswire/ ... developer of advanced medical technology for non-invasive surgery, ... the Mirabilis System for treatment of uterine fibroids ... that it had received approval from the US ... study of the Mirabilis System in the United ...
(Date:3/23/2017)... 23, 2017 Mosaic Life Care, based in St. Joseph, Missouri ... across its network of 58 clinics, located in 22 cities, and its flagship St. ... ways to improve the delivery of health care to its patients, including the insurance, ... ... Mosaic Life Care St. Joseph Medical Center ...
Breaking Medicine Technology: